NasdaqCM - Delayed Quote USD

Nutex Health Inc. (NUTX)

0.6616 +0.0087 (+1.33%)
At close: April 26 at 4:00 PM EDT
0.6639 +0.00 (+0.35%)
After hours: April 26 at 7:46 PM EDT
Key Events
Loading Chart for NUTX
DELL
  • Previous Close 0.6529
  • Open 0.6900
  • Bid 0.6370 x 700
  • Ask 0.6755 x 700
  • Day's Range 0.6367 - 0.6900
  • 52 Week Range 0.5000 - 9.2400
  • Volume 93,852
  • Avg. Volume 270,644
  • Market Cap (intraday) 32.878M
  • Beta (5Y Monthly) 1.14
  • PE Ratio (TTM) --
  • EPS (TTM) -1.0500
  • Earnings Date May 13, 2024 - May 17, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 6.00

Nutex Health Inc. operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment owns and owns and leases land and hospital building. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. It also provides operational and managerial services, including management, billing, collections, human resources and recruiting, legal, accounting, and marketing. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas.

www.nutexhealth.com

800

Full Time Employees

December 31

Fiscal Year Ends

Recent News: NUTX

Performance Overview: NUTX

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

NUTX
75.50%
S&P 500
6.92%

1-Year Return

NUTX
92.12%
S&P 500
25.26%

3-Year Return

NUTX
--
S&P 500
11.29%

5-Year Return

NUTX
--
S&P 500
11.29%

Compare To: NUTX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NUTX

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    32.88M

  • Enterprise Value

    286.63M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.12

  • Price/Book (mrq)

    0.54

  • Enterprise Value/Revenue

    1.16

  • Enterprise Value/EBITDA

    -19.66

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -18.49%

  • Return on Assets (ttm)

    -0.19%

  • Return on Equity (ttm)

    -43.55%

  • Revenue (ttm)

    247.65M

  • Net Income Avi to Common (ttm)

    -45.79M

  • Diluted EPS (ttm)

    -1.0500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    22M

  • Total Debt/Equity (mrq)

    348.59%

  • Levered Free Cash Flow (ttm)

    472.97k

Research Analysis: NUTX

Analyst Price Targets

6.00
6.00 Average
0.6616 Current
6.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: NUTX

Fair Value

0.6616 Current
 

Dividend Score

0 Low
NUTX
Sector Avg.
100 High
 

Hiring Score

0 Low
NUTX
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
NUTX
Sector Avg.
100 High
 

People Also Watch